As part of our current initiatives, our lab is building a powerful new AI-human collaboration platform to accelerate discovery. Starting with glioblastoma, this system will:
- Integrate tumor, blood, imaging (MRI), and clinical outcome data
- Spot hidden patterns of immune escape and therapy resistance
- Predict which treatments are most likely to work for each patient
- Prioritize new targets for clinical trials faster and more precisely
Our goal is to shift cancer research from trial-and-error to precision-guided discovery, making it faster and safer to match patients with the best treatments. While glioblastoma is our starting point, everything we are building is designed to extend across many cancer types in the future. Through these efforts, and with strong partnerships with patient advocates and collaborators worldwide, we are working to bring the most advanced science directly to the people who need it most.
Visual abstract of the predicted outcomes of our AI-human collaboration platform for glioblastoma